Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
NCT03210740
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
AM001 Cream, 7.5%
DRUG:
Vehicle Cream
Sponsor
AmDerma